Lyka Labs Limited (LYKALABS)
₹162.16
INR-2.45(-1.49%)
As of December 6, 2024 10:00:00 AMLyka Labs Limited Share Price Information
24 hour Low and High
The lowest and highest prices reached in the last 24 hours of trading
Low: ₹164.61
High: ₹174
All time High
The highest price the stock has ever reached since being listed
₹254.30
Price Change 1h
Price change in the last hour of trading
+₹-2.45 +-1.49%
Price Change 1d
Price change over the last trading day
+₹-2.45 +-1.49%
Price Change 1w
Price change over the last week of trading
+₹19.38 +13.57%
Lyka Labs Limited Market Information
Exchange
The Exchange where the trading of the stock takes place
NSE
Market Cap
The current market capitalisation of the stock
507.97 Cr
About Lyka Labs Limited Share
Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations and active pharmaceutical ingredients across various therapeutic segments in India. The company manufactures and sells various formulations, including emollient, topical steroid, antifungal agent, topical anti-bacterial, acne management, dermatological formulation, pain killer, anti-aging, cleansing lotion, hair care, anti-dandruff shampoo, sunscreen, anti-acne, cosmeceutical, anti-oxidant, proton pump inhibitor, nutraceuticals, anti-malarial, anti-bacterial, corticosteroid hormones, cephalosporin, dry powder injection, bone resorption inhibitor, anti-oxidant/liver disease, antibiotic, and lyophilized products. It also offers contracted manufacturing services to various large pharmaceutical companies; and medical and technical assistance in the areas of manufacturing know how and manufacturing facilities, as well as technical data, such as molecule stability testing data, impurity profile, and BA/BE clinical study data. In addition, it provides products and services in therapeutic categories, such as intensive care, gastroenterology, anti-infective, anti-fungal, surgery care, cosmetologist, urology, wound care, and anesthesia. The company offers its products in various forms, including injections, creams, ointments, foams, gels, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.
Sector
Healthcare
Biotechnology
Employees
about
423
CEO
Mr. Kunal Narendra Gandhi
Revenue (2023)
%
Country of Origin
India
Key Highlights
- There's Reason For Concern Over Lyka Labs Limited's (NSE:LYKALABS) Massive 36% Price Jump
- Lyka Labs Stock Surges, Reaches 52-Week High and Outperforms Sector
- Lyka Labs shares hit new 52-week high after Ipca Laboratories acquires 48 lakh shares of the company
- Our Take On Lyka Labs Limited’s (NSE:LYKALABS) CEO Salary
Lyka Labs Limited Resource
FAQs
The current price of Lyka Labs Limited is INR 162.16 — it has changed by -1.49% in the past 24 hours. Watch Lyka Labs Limited's stock price performance more closely on the chart.
Lyka Labs Limited has a market capitalization of 5079730176 as of today.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Lyka Labs Limited's EBITDA is INR undefined
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Lyka Labs Limited stocks are traded under the ticker [object Object]
As of December 08, 2024, the company has 423 employees.